Kevin Freeman

Track

Insider profile

Currently holds a position at Galectin Therapeutics Inc

Performance

Overall performance
3.2
Performance over holding periods
3.2
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 55% 68% 82%
Transactions
23 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Galectin Therapeutics Inc May 26, 2011 -
Kevin Freeman's trades of Galectin Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
272.48
Quantity 56,449 +44.1%
Value US$395,103
Transaction date
Purchase
Price
159.00
Quantity 98,935 +3.6%
Value US$1,789,316
Transaction date
Purchase
Price
285.64
Quantity 86,394 -27.5%
Value US$3,133,961
Transaction date
Purchase
Price
2.64
Quantity 1,300 +3.9%
Value US$3,432
Transaction date
Purchase
Price
2.70
Quantity 5,000 +17.6%
Value US$13,500
Transaction date
Purchase
Price
2.38
Quantity 2,500 +9.6%
Value US$5,950
Transaction date
Purchase
Price
2.98
Quantity 2,500 +10.7%
Value US$7,450
Transaction date
Proposed sale
Price
1.67
Quantity 7,571
Value US$12,681
Transaction date
Purchase
Price
4.28
Quantity 1,426 +6.5%
Value US$6,103
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-23 2025-12-23
B Purchase
56,449 +44.1%
272.48
US$395,103 		56,449 +44.1% 272.48 US$395,103
2025-07-18 2025-07-17
B Purchase
98,935 +3.6%
159.00
US$1,789,316 		98,935 +3.6% 159.00 US$1,789,316
2024-12-26 2024-12-24
B Purchase
86,394 -27.5%
285.64
US$3,133,961 		86,394 -27.5% 285.64 US$3,133,961
2024-10-17 2024-10-17
B Purchase
1,300 +3.9%
2.64
US$3,432 		1,300 +3.9% 2.64 US$3,432
2024-10-16 2024-10-16
B Purchase
5,000 +6.7%
2.70
US$13,500 		5,000 +6.7% 2.70 US$13,500
2024-10-16 2024-10-16
B Purchase
5,000 +17.6%
2.70
US$13,500 		5,000 +17.6% 2.70 US$13,500
2024-06-20 2024-06-20
B Purchase
2,500 +9.6%
2.38
US$5,950 		2,500 +9.6% 2.38 US$5,950
2024-04-22 2024-04-22
B Purchase
2,500 +10.7%
2.98
US$7,450 		2,500 +10.7% 2.98 US$7,450
2023-09-11 2023-09-07
PrS Proposed sale
7,571
1.67
US$12,681 		7,571 1.67 US$12,681
2022-10-31 2022-10-28
B Purchase
10,000 +15.4%
1.41
US$14,100 		10,000 +15.4% 1.41 US$14,100
2022-05-20 2022-05-19
B Purchase
5,000 +8.3%
1.33
US$6,650 		5,000 +8.3% 1.33 US$6,650
2022-04-18 2022-04-18
B Purchase
5,000 +9.1%
1.71
US$8,550 		5,000 +9.1% 1.71 US$8,550
2022-01-19 2022-01-19
B Purchase
5,000 +11.1%
1.96
US$9,806 		5,000 +11.1% 1.96 US$9,806
2021-12-15 2021-12-06
B Purchase
5,000 +11.1%
2.28
US$11,400 		5,000 +11.1% 2.28 US$11,400
2021-12-06 2021-12-06
B Purchase
5,000 +12.5%
2.34
US$11,700 		5,000 +12.5% 2.34 US$11,700
2021-11-01 2021-10-29
B Purchase
2,000 +5.3%
3.17
US$6,340 		2,000 +5.3% 3.17 US$6,340
2021-10-21 2021-10-21
B Purchase
2,000 +5.6%
3.19
US$6,380 		2,000 +5.6% 3.19 US$6,380
2021-10-19 2021-10-19
B Purchase
3,000 +9.1%
3.37
US$10,107 		3,000 +9.1% 3.37 US$10,107
2021-04-06 2021-04-05
B Purchase
5,000 +20.0%
2.04
US$10,200 		5,000 +20.0% 2.04 US$10,200
2020-09-09 2020-09-04
B Purchase
5,000 +25.0%
2.57
US$12,848 		5,000 +25.0% 2.57 US$12,848
2020-03-20 2020-03-19
B Purchase
6,000 +42.9%
1.64
US$9,844 		6,000 +42.9% 1.64 US$9,844
2019-09-09 2019-09-06
B Purchase
1,290 +13.3%
3.71
US$4,786 		1,290 +13.3% 3.71 US$4,786
2019-06-03 2019-05-31
B Purchase
1,426 +6.5%
4.28
US$6,103 		1,426 +6.5% 4.28 US$6,103
2019-06-03 2019-05-31
B Purchase
7,710 +385.5%
4.28
US$32,999 		7,710 +385.5% 4.28 US$32,999
2019-04-08 2019-04-05
B Purchase
500 +33.3%
4.73
US$2,365 		500 +33.3% 4.73 US$2,365
2019-02-11 2019-02-08
B Purchase
1,500 +inf%
4.29
US$6,428 		1,500 +inf% 4.29 US$6,428